Critical Alert

Luxembourg maintaining COVID-19-related entry restrictions as of Oct. 7. Mandatory domestic social-distancing measures in effect. 

Alert Begins 07 Oct 2020 02:46 PM UTC
Alert Expires 30 Oct 2020 11:59 PM UTC


  • Event: COVID-19 Restrictions
  • Location(s): Nationwide 
  • Time Frame: Indefinite
  • Impact: Travel and business disruptions remain


Authorities in Luxembourg are maintaining international entry restrictions as of Oct. 7 as part of efforts to combat the spread of coronavirus disease (COVID-19). No entry restrictions apply to travelers from the European Economic Area, Switzerland, and the UK; residents of Australia, Canada, Georgia, Japan, New Zealand, Rwanda, South Korea, Thailand, Tunisia, and Uruguay are also permitted to enter the country. Any travelers arriving by air from a country not listed above will require evidence of a negative COVID-19 test result taken within 48 hours prior to departure. Most travelers from elsewhere are prohibited from entry until at least Dec. 31.

Most businesses, facilities, and services have resumed operations, though protective facemasks are mandatory on public transport and in enclosed or crowded public spaces where a 2-meter (6.5 feet) distance cannot be maintained between members of different households.

Authorities could reimpose, extend, further ease, or otherwise amend any restrictions with little-to-no notice depending on disease activity over the coming weeks.


Background and Analysis
Authorities could reintroduce sporadic, targeted measures in response to further COVID-19 outbreaks. Such measures could apply to neighborhoods or specific facilities, including schools, factories, or accommodation and office blocks. Mandatory social distancing procedures in public places and on public transport, as well as widespread voluntary "self-policing" by residents, will assist in reducing the potential for contagion, negating the necessity for a large-scale, blanket reintroduction of significant restrictions.

COVID-19 is a viral respiratory disease caused by infection with the SARS-CoV-2 virus (previously known as 2019-nCoV). Symptoms occur 1-14 days following exposure (average of 3-7 days). These symptoms include fever, fatigue, cough, difficulty breathing, sometimes worsening to pneumonia and kidney failure - especially in those with underlying medical conditions.


Follow all official instructions. Carry proper identification documents to present at security checks. Heed all official advisories and remain nonconfrontational if stopped by authorities. Consider delaying travel if experiencing symptoms associated with COVID-19. Liaise with trusted contacts for further updates and guidance. Maintain contact with your diplomatic representation. Ensure contingency plans account for further disruptive measures or extensions of current restrictions.

Emphasize basic health precautions, especially frequent handwashing with soap and water, or an alcohol-based hand sanitizer if soap and water are unavailable. Practice good coughing/sneezing etiquette (i.e., covering coughs and sneezes with a disposable tissue, maintaining distance from others, and washing hands). There is no evidence that the influenza vaccine, antibiotics, or antiviral medications will prevent this disease, highlighting the importance of diligent basic health precautions.



Back to the COVID-19 Risk Intelligence & Resource Center